Asia-Pacific's largest Healthcare Expo Taiwan will take place from December 5 to 8, focusing on turning opportunities into tangible results. With over 2,000 international buyers visiting Taiwan, the expo is set to showcase cutting-edge medical technologies, including AI solutions, imaging diagnostics hardware and software, telemedicine platforms, cell storage systems, and oncology diagnostics. The event is projected to generate business collaborations worth billions of NTD.
To facilitate connections between buyers and local companies, the expo's organizers began matchmaking talks as early as November. The Middle Eastern delegation has been particularly proactive, with major buyers such as Qatar's leading distributor, Aamal Company Q.P.S.C., and UAE-based Al Khayyat Investments, a market leader with exclusive rights to tens of thousands of products.
Taiwanese industry leaders such as InnoCare Optoelectronic, Advantech, Quanta, Qisda, ASUS, Inventec, AUO Display Plus, and HIWIN have successfully initiated negotiations with Middle Eastern buyers, with formal contracts expected to be signed during the event.
The Healthcare Expo Taiwan is the world's first large-scale professional event integrating healthcare, ICT, technology, biotech, pharmaceuticals, and medical devices to create a comprehensive health industry ecosystem. Centered around hospitals, this year's expo emphasizes smart healthcare, precision medicine, and health for all ages. In addition to Middle Eastern buyers, dozens of medical groups and hospital executives from across the globe are set to attend. Industry experts view this year’s expo as a landmark event likely to generate substantial orders for exhibitors.
The MEDTEX Summit Asia, an innovative healthcare forum taking place on December 3 and 4, will serve as a prelude to the expo. Featuring innovation teams incubated by global pharmaceutical giants like Johnson & Johnson and Merckas well as projects from major international venture capital firms such as Insight Partners, Temasek, MassMutual, and ARCH Venture, the forum promises to ignite excitement in Taiwan's biotech investment landscape. Local firms with strong licensing credentials, such as Alar Pharmaceuticals and Pharmosa Biopharm, will showcase their technologies in head-to-head demonstrations.
This year’s forum focuses on technological innovation and capital partnerships, drawing domestic venture capitalists, private equity funds, corporate leaders, and professional investors seeking promising investment opportunities.
The Institute for Biotechnology and Medicine Industry (IBMI) highlighted that the Healthcare Expo Taiwan not only aims to attract international procurement teams but also seeks to encourage global startups to raise funds in Taiwan. The IBMI hopes this event will broaden the horizons of Taiwan’s investment community while showcasing Taiwan's capital strength to the world.
Resource: 醫療科技展12／5登場 拚創千億商機
